Site US10004 — Indianapolis, Indiana

Site US10004 is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Site US10004 has participated in 2 clinical trials.

Therapeutic areas: Clostridium Difficile-associated Diarrhea (CDAD), HER2 Amplified, Advanced Breast Cancer.

Sponsors: Astellas Pharma Europe B.V., Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US10004?

Site US10004 has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US10004 conducted?

Site US10004 has 2 clinical trials on record. Their work covers Clostridium Difficile-associated Diarrhea (CDAD), HER2 Amplified, Advanced Breast Cancer.

Is Site US10004 accredited by Crixeo Health?

Site US10004 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US10004?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.